m.ibarra
TL2 · Rosario
Contributes reviews on supplier material. Based in Rosario.
Joined 21 August 2025 · last posted 2d
84 posts, newest first. Showing up to 150.
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #96 · Wellbeing › Sleep · 26 Jul 2026 · 17 likes Consistency of timing does more for most people's sleep than any intervention discussed in this subcategory. I keep a log of this specifically because memory is…
-
How shortages have affected compounding permissions Replied, post #63 · Access › Shortages · 23 Jul 2026 · 4 likes Coming back to post #61, because the follow-up matters more than the original answer. The published shortage register maintained by the national regulator is the…
-
Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #22 · Analytics › COA interpretation · 23 Jul 2026 · 0 likes Reading this Batch date thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
-
Revisiting: Theoretical plates: useful number or ritual? Replied, post #18 · Analytics › HPLC & UHPLC · 8 Jul 2026 · 15 likes Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #91 · Compounds › Semaglutide · 5 Jul 2026 · 1 like Injection site does not appear to matter much for semaglutide exposure. The published comparisons of abdomen, thigh and upper arm found differences small enough to be…
-
Angle of injection and whether 90 degrees is always right — the long version Replied, post #37 · Practice › Administration · 3 Jul 2026 · 28 likes Post #36 answers the question as asked. The question underneath it is different. An honest declaration on Angle of injection: I have a prior here and it is strong…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #53 · Compounds › Secretagogues & GH axis · 28 Jun 2026 · 3 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Submitting a sample: the process end to end Replied, post #30 · Sourcing › Independent verification · 21 Jun 2026 · 18 likes Submitting a sample sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
-
About the Syringes & needles category Replied, post #4 · Devices › Syringes & needles · 18 Jun 2026 · 16 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #55 · Evidence › Journal club · 10 Jun 2026 · 6 likes I read post #51 twice before replying, because I had assumed the opposite. Reading order that works for these sessions: registry entry, methods, baseline table, primary…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #57 · Access › Insurance & coverage · 5 Jun 2026 · 0 likes Adding what did not work for me on appeal, since the failures never get written up and they are half the useful information.
-
Purity assay versus content assay: two different numbers Replied, post #4 · Analytics › COA interpretation · 5 Jun 2026 · 7 likes Coming back to the opening post, because the follow-up matters more than the original answer. The single most useful discipline: read the document for what it does not…
-
Manufacturer assistance programmes and their eligibility rules Replied, post #31 · Access › Pricing · 4 Jun 2026 · 0 likes Nothing here is financial advice and none of it is a route to a transaction.
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #35 · Compounds › Repair & healing peptides · 2 Jun 2026 · 0 likes I had written a reply contradicting post #31 and deleted it. Here is what survived. Stability in solution is the practical constraint. Dry, these keep well;…
-
Bioimpedance and hydration: why the number moves Replied, post #51 · Outcomes › Body composition · 27 May 2026 · 24 likes Post #49 answers the question as asked. The question underneath it is different. Percentage body fat is a ratio, so it changes when either component changes. A rising…
-
How to disagree with an answer you were given, well Replied, post #2 · Start Here › How to Ask · 23 May 2026 · 20 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. Flagging that the sources on this are…
-
Alcohol: what is documented and what is folklore Replied, post #20 · Practice › Interactions · 20 May 2026 · 0 likes I keep a log for alcohol specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and settled it.
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #45 · Meta › Announcements · 12 May 2026 · 12 likes Post #42 answers the question as asked. The question underneath it is different. Trust level 3 requirements is well covered in the tag pages, and the older discussions…
-
Revisiting: Primary endpoint hierarchies and why order matters Replied, post #14 · Evidence › Trials · 9 May 2026 · 6 likes Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least one by random chance increases. This is why…
-
Micro-titration: a disputed topic, argued properly Replied, post #71 · Practice › Dosing & titration · 8 May 2026 · 14 likes Building on post #68 rather than restating it. A titration plan written down in advance is easier to stick to and easier to abandon deliberately. An improvised one…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #18 · Analytics › Home & field testing · 28 Apr 2026 · 12 likes The honest cost comparison is a home kit against a single independent submission. For most people the second answers the question and the first answers a different,…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #79 · Research Methods › Statistics · 15 Apr 2026 · 22 likes This settles it for me, at least until somebody posts a reason it should not.
-
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #33 · Outcomes › Body composition · 8 Apr 2026 · 0 likes Coming back to post #31, because the follow-up matters more than the original answer. Worth separating Ultrasound and skinfolds as a question about the compound from…
-
Second pass at: Identical chromatograms across two different lots Replied, post #25 · Sourcing › Red flags · 24 Feb 2026 · 3 likes Adding the boring version of Identical chromatograms, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary…
-
What I would record differently if I started again Started this topic · Outcomes › Progress reports · 23 Feb 2026 · 7 likes Asking directly, because I could not find a straight answer: What I would record differently if I started again Asking about the phase almost nobody writes about. The…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #69 · Outcomes › Progress reports · 16 Feb 2026 · 5 likes Longitudinal report with the method stated: same scale, same time of day, same conditions. A scale is a tool; use the same one each time. Consistency matters more than…
-
MHRA statements, read directly Replied, post #79 · Regional › UK & Ireland · 31 Jan 2026 · 31 likes Thank you for the correction. I would rather find out here than later.
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #22 · Practice › Storage & stability · 20 Jan 2026 · 15 likes Answering the question post #19 raises rather than the one it answers. Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #15 · Practice › Administration · 15 Jan 2026 · 0 likes Letting a refrigerated preparation come to room temperature before injecting reduces the sting for most people. It is not a stability requirement, it is a comfort one,…
-
Request: export my own posts — one year on Replied, post #33 · Meta › Feature requests · 12 Jan 2026 · 31 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Tracking that stops updating and then resumes — the long version Replied, post #58 · Sourcing › Logistics · 29 Dec 2025 · 0 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance. I am describing what is, rather than arguing for what…
-
[2026 update] Availability by country, dated, with primary sources Started this topic · Access › International · 10 Dec 2025 · 23 likes On the subject in the title: Availability by country, dated, with primary sources Working notes rather than a conclusion. Documenting an access outcome, dated, because…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #64 · Clinical › Special populations · 9 Dec 2025 · 0 likes The number people quote for Older adults is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly uninformative…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #4 · Access › International · 6 Dec 2025 · 18 likes Worth separating two things that post #2 runs together. Summarising the Language barriers in accessing thread so far, since it is long and the answer is buried: the…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #140 · Start Here › How to Ask · 25 Nov 2025 · 0 likes If your question has a deadline — a parcel in transit, a delivery you have to accept or refuse — say so. People answer differently when there is a clock on it.
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #66 · Pharmacology › Receptor biology · 14 Nov 2025 · 0 likes Building on post #63 rather than restating it. Amylin signalling reaches satiety through a distinct receptor complex, which is the mechanistic basis for expecting an…
-
Reading an interaction checker output critically Replied, post #35 · Practice › Interactions · 3 Nov 2025 · 5 likes That is the distinction I keep failing to hold on to. Written down now.
-
Amylin receptor signalling and satiety Replied, post #20 · Pharmacology › Receptor biology · 30 Oct 2025 · 7 likes GLP-1 receptor signalling: the GLP-1 receptor is expressed on beta cells (insulin secretion), on neurons (appetite and gastric motility), and on myocardium…
-
Second pass at: Programming during a large energy deficit Replied, post #50 · Nutrition & Training › Resistance training · 23 Oct 2025 · 17 likes That reframing is the whole thing. The facts I already had.
-
A preprint whose numbers changed substantially at publication Replied, post #64 · Evidence › Preprints · 23 Sep 2025 · 21 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
Pooling trials with different estimands — what changed since Replied, post #28 · Evidence › Meta-analyses · 23 Sep 2025 · 16 likes Overlapping populations across included trials inflate the apparent sample size. It happens more than people expect where the same programme reports multiple papers.
-
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #3 · Evidence › Preprints · 10 Aug 2025 · 3 likes Screening on a preprint server is minimal and is not review. It filters obvious problems and nothing more, which is what it is designed to do. Not a strong opinion,…
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #34 · Start Here › How to Ask · 4 Aug 2025 · 1 like This follows post #32 rather than contradicting it. Say what you want out of the answer. "I want to know whether to accept this delivery" and "I want to understand the…
-
How to research a compound with no human data without deceiving yourself Replied, post #104 · Compounds › Other compounds · 4 Aug 2025 · 16 likes Agreed on all of that, and I have nothing to add to it.
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #16 · Practice › Storage & stability · 30 Jul 2025 · 0 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear.
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #91 · Compounds › Tirzepatide · 20 Jul 2025 · 29 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
-
Repeatability versus intermediate precision Replied, post #124 · Analytics › Method validation · 2 Jul 2025 · 24 likes Marking my uncertainty on repeatability versus intermediate precision explicitly. I am confident about the direction, much less confident about the size, and not…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #54 · Compounds › Repair & healing peptides · 30 Jun 2025 · 7 likes Dose-response is unstudied in humans for essentially everything in this family, which means the confident numbers in circulation came from somewhere other than a trial.…
-
Washout: how long is long enough, and for what purpose Replied, post #39 · Pharmacology › Pharmacokinetics · 26 Jun 2025 · 24 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #115 · Compounds › Cagrilintide & amylin analogues · 16 Jun 2025 · 11 likes Where I part company with post #113, and it is a narrow parting. The phase 3 combination programme is where the clinically interesting numbers will come from. Phase 2…
-
Half-life, steady state, and accumulation worked through Replied, post #121 · Pharmacology › Pharmacokinetics · 15 Jun 2025 · 18 likes Half-life determines how quickly concentration approaches steady state and does not determine what the steady-state concentration is. Dose and clearance determine that.…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #25 · Nutrition & Training › Protein & intake · 5 Jun 2025 · 12 likes The reason Tracking intake keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #16 · Sourcing › Regulatory · 2 Jun 2025 · 18 likes Taking post #15 at face value and following it one step further. A compound in a compounding pathway in one country and unavailable in another is a common situation and…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #14 · Analytics › Home & field testing · 10 May 2025 · 3 likes Right, and stated more narrowly than I would have dared to state it.
-
Which panel is worth repeating and which is worth ignoring Replied, post #15 · Clinical › Bloodwork · 8 May 2025 · 18 likes That is clearer than the version I had in my head. Thank you.
-
When to stop reading forums, including this one — the long version Started this topic · Wellbeing › Mental health · 22 Apr 2025 · 0 likes Asking directly, because I could not find a straight answer: When to stop reading forums, including this one — the long version Something that has come up for me and…
-
Reading a chromatogram someone posted without axes Replied, post #24 · Analytics › HPLC & UHPLC · 22 Apr 2025 · 12 likes A chromatogram image at a resolution where you can see peak shape but not baseline detail is worth having and is not the same as the data. Ask for the integration table…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #62 · Analytics › Mass spectrometry · 10 Apr 2025 · 0 likes Before the thread moves on from adducts — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of four and…
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #21 · Sourcing › Vendor reports · 25 Mar 2025 · 0 likes Photograph the vial and the label before opening. It costs ten seconds and it is what turns a report into something checkable. Old habit: I write down the expected…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #114 · Pharmacology › Receptor biology · 17 Mar 2025 · 8 likes Nothing in receptor biology tells you what is in the vial, which is worth remembering when a mechanistic thread starts being used to justify a sourcing decision.
-
Maintainer handover: how it works Replied, post #8 · Meta › Wiki maintenance · 12 Mar 2025 · 0 likes Volunteering for the review on this one. I use it monthly, I have a list of three things that have aged badly, and I am willing to be named as the second maintainer.
-
Anxiety in the first weeks: drug, situation, or both Replied, post #60 · Wellbeing › Mental health · 11 Mar 2025 · 0 likes Mood and anxiety: mood changes and anxiety are reported by some people. Baseline mental health status matters for risk. Someone with a history of depression should plan…
-
A page that has drifted out of date and needs a maintainer Replied, post #72 · Documentation › Wiki requests · 5 Mar 2025 · 16 likes Flag a page that has drifted: if you notice a maintained page has information that is outdated (dates that have passed, regulatory changes, new evidence) post a flag so…
-
Holding a dose indefinitely: is there a documented downside? Replied, post #11 · Practice › Dosing & titration · 23 Feb 2025 · 0 likes Dose and effect are not linear across the studied range for every compound in this class. Assuming a doubled dose gives a doubled effect is the reasoning error behind…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #8 · Compounds › Cagrilintide & amylin analogues · 7 Feb 2025 · 24 likes Worth separating two things that post #7 runs together. Cagrilintide alone is discussed less than in combination because the published data is almost entirely from…
-
A supplier that answers analytical questions with restated claims Replied, post #14 · Sourcing › Red flags · 24 Jan 2025 · 3 likes Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way that allows accountability. I have changed my mind on…
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #26 · Clinical › Bloodwork · 21 Jan 2025 · 0 likes What would change my mind on Lipid changes during rapid weight is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I…
-
Distinguishing a deletion sequence by mass alone Replied, post #4 · Analytics › Mass spectrometry · 19 Jan 2025 · 6 likes Adding the measurement that the opening post says would settle it. Monoisotopic and average mass are different numbers and both appear on documents. At this molecular…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #82 · Compounds › Semaglutide · 11 Jan 2025 · 32 likes This is the answer, and the reason it is the answer is the more useful part.
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #24 · Evidence › Journal club · 9 Jan 2025 · 2 likes Confirming post #22 from a second method, which matters more than confirming it from a second person. The strongest argument against my own position on SUSTAIN 6,…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #102 · Compounds › Semaglutide · 25 Dec 2024 · 30 likes Seconded. It reads as careful rather than confident, which is the right register.
-
Building a sensible monitoring schedule with your prescriber Replied, post #82 · Clinical › Bloodwork · 22 Dec 2024 · 20 likes A trend needs at least three points to be a trend. Two points are a line and a line through noise is still a line. That much is documented. The rest is how I have…
-
What changed in 2026, by region Replied, post #13 · Access › International · 8 Dec 2024 · 17 likes Travel with medication: carrying a compound across borders is complicated by legal status. Documenting that it is prescribed and carrying proof reduces (but does not…
-
Revisiting: Moderation log format change Replied, post #58 · Meta › Announcements · 7 Dec 2024 · 3 likes Practical question on the rollout: will it be visible that a topic was created before or after the change? Six months from now nobody will remember the date. Marking…
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #39 · Sourcing › Regulatory · 26 Nov 2024 · 25 likes Adding what did not work for me on Research-use-only labelling, since the failures never get written up and they are half the useful information.
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #38 · Clinical › Special populations · 22 Nov 2024 · 1 like Answering the question post #36 raises rather than the one it answers. A definition problem is doing most of the work in this Type 1 diabetes discussion. Once the term…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #24 · Compounds › Other compounds · 21 Nov 2024 · 0 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #41 · Compounds › Repair & healing peptides · 12 Nov 2024 · 24 likes An update on my earlier reading a preclinical wound-healing model post: the pattern held for another six weeks and then stopped, which I did not predict and cannot…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #46 · Compounds › Tirzepatide · 1 Nov 2024 · 22 likes Posting my SURPASS-2 numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a particular…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #21 · Clinical › Bloodwork · 10 Sep 2024 · 0 likes Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing is not a contradiction; it is two different questions. That is…
-
Reporting a discrepancy without making an allegation Replied, post #66 · Sourcing › Vendor reports · 10 Sep 2024 · 4 likes Distinguishing three things in the reporting a discrepancy discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the…
-
Correlation in a self-tracked dataset: what it can support Replied, post #82 · Research Methods › Statistics · 23 Aug 2024 · 0 likes Time-to-event analysis handles differing follow-up in a way a simple proportion cannot, which is why event rates and Kaplan-Meier estimates can differ. Speaking for…
-
Correlation in a self-tracked dataset: what it can support Replied, post #63 · Research Methods › Statistics · 22 Aug 2024 · 23 likes On correlation I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how threads…
-
Why our vendor pages link the storefront and mark it sponsored Replied, post #5 · Sourcing › Vendor reports · 18 Aug 2024 · 22 likes Adding a note of thanks rather than an opinion. I did not know most of that.